Patients revived from an opioid overdose who get methadone or Suboxone treatment for addiction afterward are much more likely to be alive a year later, says a study published in the Annals of Internal Medicine.Kaiser Health News (Source: Medscape Medical News Headlines)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

{ 0 comments }

Dr Reddy’s said in a BSE filing that the company remains confident in its legal positions on this patent. (Source: The Economic Times Healthcare and Biotech News)

{ 0 comments }

FDA approves first generic Suboxone

June 18, 2018

Mylan and Dr. Reddy’s Laboratories have both received FDA approval to make the first generic versions of a Suboxone under-the-tongue film for the treatment of opioid addiction. (Source: PharmaManufacturing.com) MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

Read the full article →

FDA approves first generic sublingual film to treat opioid addiction

June 16, 2018

The FDA this week approved the first generic version of Indivior‘s (LON:INDV) billion-dollar opioid addiction treatment, Suboxone. The generic buprenorphine and naloxone sublingual film, sold by Dr. Reddy’s Laboratories (NYSE:RDY) and Mylan (NSDQ:MYL), is designed to suppress withdrawal symptoms that crop in people addicted to opioids, as well as block the neurochemical effects of opioids. Get the […]

Read the full article →

FDA Approves First Generic Under-the-Tongue Suboxone

June 16, 2018

FRIDAY, June 15, 2018 — The first generic version of an under-the-tongue film to treat opioid addiction has been approved by the U.S. Food and Drug Administration. The generic version of Suboxone (buprenorphine and naloxone) film from Mylan… (Source: Drugs.com – Pharma News) MedWorm Message: Have you tried our new medical search engine? More powerful […]

Read the full article →

FDA Approves First Generic Versions of Suboxone Sublingual Film, Which May Increase Access to Treatment for Opioid Dependence

June 15, 2018

June 14, 2018 — The U.S. Food and Drug Administration today approved the first generic versions of Suboxone (buprenorphine and naloxone) sublingual film (applied under the tongue) for the treatment of opioid dependence. “The FDA is taking new… (Source: Drugs.com – Pharma News) MedWorm Message: If you are looking to buy something in the January […]

Read the full article →

FDA approves first generic versions of Suboxone sublingual film, which may increase access to treatment for opioid dependence

June 15, 2018

: FDA approved the first generic versions of Suboxone (buprenorphine and naloxone) sublingual film (applied under the tongue) for the treatment of opioid dependence. (Source: Food and Drug Administration)

Read the full article →

FDA clears 1st generic film strip of addiction drug Suboxone

June 15, 2018

U.S. regulators approve 1st generic version of an under-the-tongue treatment for opioid addiction (Source: ABC News: Health)

Read the full article →

FDA Clears First Generic Versions of Suboxone Sublingual Film FDA Clears First Generic Versions of Suboxone Sublingual Film

June 15, 2018

Generic buprenorphine and naloxone sublingual film may increase access to treatment for opioid dependence, the agency said.FDA Approvals (Source: Medscape Medical News Headlines)

Read the full article →

Dr Reddy's Laboratories gets USFDA nod for generic version of Suboxone

June 15, 2018

The company, which is launching the product in the US, said approval has been granted in the strengths of 2 mg/0.5 mg, 4 mg/1 mg, 8 mg/2 mg, and 12 mg/3 mg. (Source: The Economic Times Healthcare and Biotech News)

Read the full article →